What does Rapt Therapeutics, Inc. do?

Jun 22 2025 06:56 PM IST
share
Share Via
Rapt Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing oral small molecule therapies for oncology and inflammatory diseases. It has a market cap of $129.64 million and reported a net profit loss of $17 million as of March 2025.
Overview:
Rapt Therapeutics, Inc. is a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -17 Million (Quarterly Results - Mar 2025)
Market cap: USD 129.64 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.00
Return on Equity: -65.69%
Price to Book: 0.73

Contact Details:
Address: 561 Eccles Ave, SOUTH SAN FRANCISCO CA: 94080-1906
Tel: 1 650 4899000
Website: https://www.rapt.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Rapt Therapeutics, Inc. technically bullish or bearish?
Sep 20 2025 08:00 PM IST
share
Share Via
Is Rapt Therapeutics, Inc. overvalued or undervalued?
Jun 25 2025 09:13 AM IST
share
Share Via
Is Rapt Therapeutics, Inc. technically bullish or bearish?
Jun 25 2025 08:59 AM IST
share
Share Via
Who are in the management team of Rapt Therapeutics, Inc.?
Jun 22 2025 10:40 PM IST
share
Share Via
How big is Rapt Therapeutics, Inc.?
Jun 22 2025 06:10 PM IST
share
Share Via
Most Read
Why is Bluestone Jewel falling/rising?
27 minutes ago
share
Share Via
Why is Borana Weaves falling/rising?
27 minutes ago
share
Share Via
Why is Malpani Pipes falling/rising?
28 minutes ago
share
Share Via
Why is Sat Kartar falling/rising?
28 minutes ago
share
Share Via
Why is Baazar Style falling/rising?
28 minutes ago
share
Share Via
Why is Agarwal Toughene falling/rising?
28 minutes ago
share
Share Via
Why is Blackbuck falling/rising?
28 minutes ago
share
Share Via